Home/Filings/5/0001053369-15-000013
5//SEC Filing

ELITE PHARMACEUTICALS INC /NV/ 5

Accession 0001053369-15-000013

$ELTPCIK 0001053369operating

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 1:53 PM ET

Size

7.3 KB

Accession

0001053369-15-000013

Insider Transaction Report

Form 5
Period: 2015-03-31
Plassche Douglas
EVP Operations
Transactions
  • Award

    Common Stock

    2015-02-27$0.34/sh+73,094$24,998158,624 total
  • Award

    Common Stock

    2014-02-25$0.11/sh+85,530$9,72585,530 total
Holdings
  • Common Stock

    0
Footnotes (3)
  • [F1]Form 3 should have been filed on or about August 12, 2013.
  • [F2]Represents the amount owned following the respective dates of the transactions and as of the end of the respective fiscal years.
  • [F3]Distribution from the Issuer.

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0001053369

Filing Metadata

Form type
5
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 1:53 PM ET
Size
7.3 KB